What Are Lab ETFs and How They Work

Harbor Capital has filed an application with the U.S. Securities and Exchange Commission (SEC) to register five actively managed funds, which Bloomberg ETF analyst James Seyffart called a "very interesting filing." Each of these funds doesn't focus on a single IPO or stock, but on the entire ecosystem of companies connected to a given AI lab — whether that means chip suppliers, cloud partners, model integrators, or companies whose product roadmaps depend on that lab. In practice, this means the OpenAI Lab ETF would most likely include Microsoft stock (as the main investor and cloud partner), key chip manufacturers, and publicly traded companies that have integrated GPT models into their products. The Anthropic Lab ETF, by contrast, would target companies closely tied to Claude models — primarily Amazon (AWS) and Google (as investors) and their ecosystem. The Meta Lab ETF will focus on open-source Llama models and the companies that use them. The Google DeepMind ETF will track the ecosystem around Gemini models. And finally, the xAI/SpaceXAI Lab ETF will offer exposure to companies linked to Elon Musk's AI lab.

Why Now? The Financialization of AI Is Gathering Pace

As the crypto analytics account MediaCrypto aptly noted: "AI ecosystem ETFs are the new sector ETFs." And they add that the financialization of AI is happening at the same pace as it did earlier with cryptocurrencies. Indeed — this isn't the first sign. The KraneShares Artificial Intelligence and Technology ETF (AGIX) already offers direct exposure to Anthropic and SpaceX via secondary markets. Funds using special purpose vehicles (SPVs) to hold pre-IPO positions in xAI and other private labs have also emerged. But Harbor Capital is going a step further — creating separate "bucket" funds for each lab individually. This will allow investors not only to bet on the entire AI sector, but to pick specific winners and losers. Do you believe more in Anthropic's safety-first approach, or OpenAI's aggressive commercialization? With Lab ETFs, you get a tool to project that opinion into your portfolio.

The Safety Backdrop: AI Labs Under Scrutiny

Harbor Capital's timing is no coincidence. AI labs have in recent months found themselves under growing regulatory and safety pressure. The Financial Times recently reported that Google DeepMind, OpenAI, and Elon Musk's xAI have agreed to let U.S. authorities conduct national security reviews of their most advanced models before their release. At the same time, former OpenAI employees warned in an open letter that xAI's "poor safety track record" poses "underappreciated risks" for investors in the anticipated $75 billion SpaceX IPO. In other words — a bet on a specific lab is not just a bet on technology, but also on its regulatory and reputational profile.

What It Means for European and Czech Investors

For Czech investors, the key question is: will these ETFs be available in Europe? For now, the answer is — probably not, at least in the initial phase. U.S. ETFs are subject to SEC regulation and would need UCITS status (or at least KIID documentation) to be offered to retail investors in the EU, a process that can take months to years. European investors, however, are not being left out. European alternatives exist such as the Xtrackers Artificial Intelligence & Big Data UCITS ETF or the WisdomTree Artificial Intelligence UCITS ETF, which offer broad exposure to the AI sector within a regulated European framework. They differ, however, in that they are broad baskets rather than lab-specific funds. Moreover, the Czech National Bank (ČNB) has recently shown growing interest in AI — as we reported earlier, it is building its own AI center for financial market supervision. This suggests that the Czech regulatory and investment ecosystem will continue to follow AI themes closely.

The Parallel with Crypto ETFs: Will the Market Learn?

For the crypto community, the story of Harbor Lab ETFs is a familiar one. Just as Bitcoin and Ethereum ETFs gave traditional investors liquid exposure to previously opaque assets, AI Lab ETFs open the door for retail and institutional investors to bet on specific AI ecosystems. However, experience from the crypto world also reveals risks: once Wall Street creates an ETF wrapper, narratives and capital flows can become self-fulfilling. Index inclusion and passive buying then shape valuations and regulatory attention — often independently of fundamentals. If Harbor Lab ETFs take off and gather assets under management, they could trigger a similar feedback loop in the AI sector: capital would concentrate into a few labs that dominate the given narrative cycle.

Risks to Consider

Investing in lab-specific ETFs brings specific risks. Concentration is one of them — if you bet on a single lab and it suffers a safety scandal, regulatory block, or loss of key talent, your exposure is fully impacted. By comparison, broad AI ETFs naturally diversify this risk. Another factor is the opacity of underlying assets. Given that many AI labs are still private (Anthropic, xAI, OpenAI), these ETFs will buy shares of publicly traded companies that are "connected" to them — however, the definition of "ecosystem" is subjective and will depend on portfolio managers' decisions.

What Comes Next

The SEC filing is only the first step. Harbor Capital has not yet published detailed prospectuses for the individual funds or their tickers. However, according to published information from slides shared by James Seyffart, there is already a clear structure: the funds will be actively managed and will focus on publicly traded companies whose revenues, strategic focus, or product plans are closely intertwined with the models, tools, and distribution channels of the given lab. Whether Harbor Capital succeeds with registration and whether investors show sufficient interest will become clear in the coming months. One thing is certain, however: financial markets are treating AI as a standalone and diversified asset class, not as a subcategory of the technology sector. And that changes the game for everyone.